The Significance of Overvaluation of Shape or Weight in Binge-Eating Disorder: Results from a National Sample of U.S. Adults.

About this resource

OBJECTIVE: This study aimed to examine the prevalence of overvaluation of shape or weight in a nationally representative sample of U.S. adults with binge-eating disorder (BED) and to compare functioning correlates using a group of adults with bulimia nervosa (BN). METHODS: Participants included 207 respondents from the National Epidemiologic Survey on Alcohol and Related Conditions who met Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) diagnoses of BED (n?=?163) or BN (n?=?44). Sociodemographic characteristics and functioning were compared in BED with overvaluation (BED+OV), BED without overvaluation (BED), and BN. RESULTS: Approximately 50% of BED respondents reported overvaluation. Mean age was lower in BN than BED. Mean BMI was lower in BED+OV than BED and higher than BN. A greater proportion of BED+OV reported functional impairment than BED. BN was more likely to report "serious problems doing daily tasks" than BED and less likely to report "impairment in normal activities" than BED+OV. BN reported significantly lower mental functioning than BED. CONCLUSIONS: Findings based on this nationally representative sample are that overvaluation was associated with greater functional impairment within BED, and BED+OV reported greater impairment than BN in interference with normal activities but less impairment related to mental health. The increased impairment associated with BED+OV provides support for overvaluation as a diagnostic specifier for BED.

AuthorCoffino, Jaime A.; Udo, Tomoko; Grilo, Carlos M.
JournalObesity (Silver Spring, Md.)

See also

Current drug treatment of patients with bulimia nervosa and binge-eating disorder: Selective serotonin reuptake inhibitors versus mood stabilizers

Our aim was to review and compare findings from controlled trials and previous reviews concerning current drug treatment of patients suffering from bulimia nervosa (BN) and binge eating disorder (BED).

Read more

Lisdexamfetamine dimesylate in binge eating disorder: A placebo controlled trial

OBJECTIVE: To evaluate lisdexamfetamine dimesylate (LDX) in the treatment of binge eating disorder (BED).

Read more

Comparison of individual and group cognitive behavioral therapy for binge eating disorder A randomized, two -year follow-up study

Introduction: Binge eating disorder (BED) is a syndrome characterized by frequent and persistent overeating episodes that are accompanied by feelings of loss of control and marked distress, in the absence of regular compensatory behaviors.

Read more

Issue 62 I Comorbid Diabetes and Eating Disorders

NEDC e-Bulletin Editor’s NoteIn our work and training across the country, the National Eating Disorders Collaboration has seen an increasing interest in the topic of eating disorders and co-occurring diabetes.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2020 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback